Navigation Links
MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
Date:7/21/2010

DALLAS, July 21, 2010 /PRNewswire/ -- According to the new market research report "Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)", published by MarketsandMarkets (http://www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion due to rising demand from U.S. and Europe.

Browse in-depth TOC on Bioinformatics Market. Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

The bioinformatics platforms market is growing at a significant pace with the increasing demand from U.S. and Europe. This trend is supported by the increasing demand for sequencing platforms with increasing life science research using techniques such as gene expression analysis, sequence analysis, and protein expression analysis.

Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality in the current competitive scenario, as there is little scope for price escalation and product differentiation.

    SCOPE AND FORMAT

    - The report analyzes the global bioinformatics market into respective
      segments:

    - Bioinformatics platforms
    - Content/knowledge management tools
    - Bioinformatics services
    - Bioinformatics applications

Analyst Briefing Presentation On Bioinformatics Market - Advanced Technologies, Global Forecast And Winning Imperatives (2009 - 2014) To Be Held On 5th Aug 2010

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on Bioinformatics Market ( http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html) - Advanced Technologies, Global Forecast And Winning Imperatives (2009 - 2014) to be held on 5th Aug 2010.

To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/bioinformatics-market.asp

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    http://www.marketsandmarkets.com
    http://marketsandmarkets.wordpress.com/
    http://marketsandmarkets.blogspot.com/


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
2. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
3. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
4. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
5. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
6. European cooperation ensures global leadership in microelectronics
7. United Nations' World Population Day Calls Attention to Key Global Issues
8. Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential
9. China Cord Blood Corporation Joins Russell Global Index
10. DuPont Leader: Global Demand for Renewable Innovations Growing
11. Reportlinker Adds Global Nucleic Acid Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017 UCHealth ( Aurora, Colorado ... pulmonary nodule patient management. In addition to optimizing care ... on the lung, UCHealth looks to improve provider workflow ... Stephanie Brown, RN , Thoracic Nurse ... with an Excel spreadsheet, which was extremely arduous and ...
(Date:2/16/2017)... , Feb. 16, 2017  Windtree Therapeutics, Inc. ... focusing on developing aerosolized KL4 surfactant therapies for ... preclinical influenza study showed that aerosolized KL4 surfactant ... a well-established preclinical animal model. The Company believes ... body of evidence that supports the role of ...
(Date:2/15/2017)... (PRWEB) , ... February 15, 2017 , ... ... Posard, as President and Chief Commercial Officer with GenePeeks. Matt is a ... , GenePeeks is a computational genomics company focused on identifying inherited disease risk ...
(Date:2/15/2017)... WASHINGTON, Feb. 15, 2017  Vanda Pharmaceuticals Inc. ... results for the fourth quarter and full year ... an exceptional year for Vanda as we continued ... and secured long-term exclusivity for Fanapt," said Mihael ... addition, our emerging pipeline with important 2017 milestones ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):